SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study

Abstract Background Immunocompromised people (ICP) and elderly individuals (older than 80 years) are at increased risk for severe coronavirus infections. To protect against serious infection with SARS-CoV-2, ICP are taking precautions that may include a reduction of social contacts and participation...

Full description

Bibliographic Details

Published in:	BMC Infectious Diseases
Main Authors:	Alexandra Dopfer-Jablonka, Sandra Steffens, Frank Müller, Marie Mikuteit, Jacqueline Niewolik, Anne Cossmann, Metodi V. Stankov, Georg M. N. Behrens, Eva Hummers, Gloria Heesen, Dominik Schröder, Sascha Roder, Frank Klawonn, Kai Vahldiek, Justin Hasenkamp, Jonathan Kallusky, Christine S. Falk, Tobias R. Overbeck, Stephanie Heinemann
Format:	Article
Language:	English
Published:	BMC 2022-04-01
Subjects:	SARS-CoV-2 COVID-19 Pandemic Humoral and cellular immunity Immunocompromised people Elderly
Online Access:	https://doi.org/10.1186/s12879-022-07347-w